ARCHIVES

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP

June 24, 1994

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

Bill Requires NIH-Funded Researchers To Send Manuscripts To PubMed Central.

November 2, 2007